Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Bulletin Du Cancer|February 9, 2023
[2022: New therapeutic practices in breast oncology]Elise Deluche, Benjamin VerretBulletin Du Cancer|June 20, 2025
[Luminal advance breast cancer: Toward personalized medicine?]Leah Mailly-Giacchetti, Benjamin VerretLa Revue Du Praticien|January 23, 2026
[Systemic treatment of bone sarcoma, soft tissue sarcoma, GIST]Nathalie Gaspar, Armelle Dufresne, Benjamin VerretCancers|September 9, 2022
The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular ProfilingBenjamin Verret, Michele Bottosso, Sofia Hervais, et al.Cancer Research|April 5, 2020
The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast CancersBenjamin Verret, Tony Sourisseau, Bojana Stefanovska, et al.Current Treatment Options in Oncology|February 7, 2024
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue SarcomasRita Khoury, Tarek Assi, Rebecca Ibrahim, et al.Journal of Bone Oncology|September 27, 2021
Chemotherapy in the management of periosteal osteosarcoma: A narrative reviewTarek Assi, Joseph Kattan, Hussein Nassereddine, et al.Current Treatment Options in Oncology|October 16, 2023
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive ReviewTarek Assi, Carine Ngo, Matthieu Faron, et al.Clinical and Experimental Medicine|February 16, 2026
Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarkerSofiane Taleb, Maxime Brunet, Laila Belcaid, et al.Anti-Cancer Drugs|December 12, 2018
5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathyAlice Boilève, Camille Wicker, Benjamin Verret, et al.Pageof 5